Quantus

MOOLEC SCIENCE

MLEC-US · Nasdaq
$6.73-6.53%
2026-07-31 close

MOOLEC SCIENCE — pricey right now, or cheap? And what signals are flashing today?

Open the exact grade & valuation bands with Pro →
Loading chart…
Close
AI Insight

Why these signals fired — only backtest-proven edge, told honestly

Why this signalSignal guide

Moving-average alignment
No

No active signal.

Explore this stock further
Review signal, financial and filing context in chat
Explore in chat →

Strong-buy signal — the real recordrecord · not a prediction

Not this one stock, but every strong-buy pick we actually published (US market). When this stock flashes the signal, it is treated by the same rule.(as of 2026-08-03)

Last 30 sessions
759 picks
Next-day win rate
58.8%
Avg next-day
+0.55%
vs market
+0.45%p

Beat the market on 57.6% of picks (each pick vs its own day’s market average).

Recent publish days (next-day win rate)
07-30 27.3%07-29 30.8%07-28 11.1%07-27 50%07-24 28.6%07-23 44.4%07-22 50%07-21 60%07-20 33.3%07-17 37.5%07-16 16.7%07-15 50%
This stock has not flashed this signal recently — the record above is the signal’s own, not this stock’s.

Entry is the latest close at publish time; next-day is the following close. “Market” is the equal-weighted average of every stock in the same market that day; delisted names are excluded from both. Fees, taxes and slippage are not included. An observed record over a short window, not a pre-registered backtest. Not investment advice.

Valuation Grades

Relative to 126 필수소비재 peers · not investment advice

Pro unlocks the composite grade, 5 factors and sector rank · ₩19,900/mo

Valuation in its own history

PER — · PBR 0.72 — own history (2021-03~) percentiles 5/100 · 97/100

PER5/100
PBR97/100

Higher indicates lower valuation relative to its history (based on earnings and book yields).

Earnings percentiles can fluctuate for cyclical companies (including loss periods), so the book basis is shown alongside. Companies with large share buybacks can have structurally high PBR. Factual information, not investment advice.

Financial safety

Reference indicatorAs of 2024
Distress zoneFinancial-metric reference signal
Altman Z'' zoneZ'' -6.30
Distress
Grey
Safe
The marker shows the current Z'' value within the displayed zones.
Altman Z''
-6.30
Beneish M-Score
0.00

Statistical manipulation-risk signal

Sloan accrual
5.80%

부실·조작 위험을 나타내는 사실 지표입니다. 투자 조언이 아니며, 검증 전이라 참고용입니다.

Factual information, not investment advice.

Earnings quality · Piotroski F-Score

4/9Moderate

Piotroski measures year-over-year financial improvement, not absolute quality.

Financial improvement score4/9

Profitability

  • Positive ROANot passed
  • Positive OCFNot passed
  • Improving ΔROAPass
  • Accruals (OCF > net income)Not passed

Leverage & liquidity

  • Lower debtNot passed
  • Higher current ratioPass
  • No new sharesNot passed

Efficiency

  • Higher gross marginPass
  • Higher asset turnoverPass

Calculation note: F7(신주)은 equity/asset 유지로 근사

Already-stable companies may score lower when year-over-year improvement is limited.

Factual information, not investment advice.

Forensic signals

Anomaly and structural signals observed in the financial statements.

Revenue qualityDanger

매출 흑자인데 영업CF 적자 (OCF/매출 -166%). 통계적 정황 신호이며 회계부정 단정이 아닙니다.

Balance sheetWarning

부채총계 급증 (+101%). 통계적 정황 신호이며 회계부정 단정이 아닙니다.

Margin trendWarning

영업외손익 급변 (영업이익 대비 479% 규모 변동) — 일회성 손익 주의. 통계적 정황 신호이며 회계부정 단정이 아닙니다.

Factual information, not investment advice.

Industry structure

USAs of 2026-08-03

필수소비재

This stock is in 필수소비재: revenue rank 115 of 120, share 0%.

115 / 1200%revenue share

Who dominates this industry?

  1. 1WMT-US32.8%
  2. 2Kroger7.1%
  3. 3Pepsico4.4%
  4. 4Archer Daniels Midland4.1%
  5. 5Procter & Gamble4.1%
  6. 6MOOLEC SCIENCE0%

Concentration

DistributedCR3 44.2%
HHI 1,259120 revenue members

HHI and CR3 are separate industrial-organization facts; they are not the polarization verdict.

Polarization

MixedConsistent

Polarization measures industry gaps and structure, not valuation, forecast, or investment advice.

Margin lens

IQR%p
9.77
Direction
확대
Level
보통
Years
9

Value lens

P90/P10
19.2
Median P/B
1.74
Level
넓음
n
104

Survivorship note: 현재 산업 멤버십을 과거 연도에 소급 적용 — 과거 진입·퇴출 기업 미반영(복원 불가)

Factual information, not investment advice.

Risk sensitivity — adverse assumptions

Metric changes under stated assumptions; not a forecast or investment advice.

Base metrics

Operating margin
-160.8%
Interest coverage
-7.8x
Return on equity (ROE)
-107.3%

Operating margin −5pp

Operating loss
Interest coverageBase -7.8x adverse case -8x
Return on equity (ROE)Base -107.3% adverse case -153.9%

Revenue −15%

Interest coverage risk
Interest coverageBase -7.8x adverse case -6.6x
Return on equity (ROE)Base -107.3% adverse case -129.9%

Interest rate +2pp

Interest coverage risk
Interest coverageBase -7.8x adverse case -5.2x
Return on equity (ROE)Base -107.3% adverse case -158%

Interest coverage limit

Already below the limit by 181.5pp

Interest coverage limit at an operating margin of 20.7%

Interest expense coverage threshold

Financials at a glance

MOOLEC SCIENCE's latest results and balance sheet. The bars track the last three periods.

Recent filings

Filings for overseas stocks are on the way. For now we cover Korean stocks only.

Like these rules? Run them automatically.

Quantus turns rules like these into backtests and automated trading — same team, free to start.

Quantus Signal · live data · not investment advice · Privacy Policy